PBC

Dược phẩm Trung ương I - Pharbaco ·UPCOM ·2026Q1

▼▼ Declining sharply

Margins remain under pressure Net margin 3.22%, −1.59pp YoY
Price
6,000
Latest close
03 Jun 2026
P/E 20.51x
P/B 0.54x
EPS 293
BVPS 11,176
ROE 2.6%
ROA 1.1%
Profit Margin 3.2%
Asset Turnover 0.34x
Equity Mult. 2.45x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, PBC is going through a period of clear decline across multiple metrics at once — the growth momentum has held across consecutive periods. What still needs to be determined is whether the business can find a stabilization point in the near term, or whether current pressure has not yet run its course.

TTM REVENUE
VND 1,066bn
+1.8%YoY
NET MARGIN
3.22%
−1.6ppYoY
TTM NET PROFIT
VND 34bn
−31.9%YoY
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 207.9 280.2 288.4 289.5 220.4 322.8 240.2 263.4 238.6 357.8 371.9 312.3
Growth -26% -3% -0% +31% -32% +34% -9% +10% -33% -4% +19%
Net Income 10.7 6.4 22.4 -5.2 19.7 6.5 15.6 8.5 13.7 0.7 15.6 8.6
Net Margin 5.13% 2.29% 7.76% -1.78% 8.93% 2.02% 6.51% 3.23% 5.75% 0.19% 4.20% 2.76%

Drivers of PBC's profit

TTM

Net profit attributable to parent declined vs last year, mainly due to lower gross profit. Supporting and offsetting drivers:

Administrative expenses ↓ 12.9bn
Other profit ↑ 6.7bn
Gross profit ↓ 21.1bn
Finance costs ↑ 12.5bn
Financial income ↓ 3.4bn
TTM

Net profit attributable to parent declined vs prior quarter, mainly due to higher finance costs. Supporting and offsetting drivers:

Administrative expenses ↓ 0.9bn
Finance costs ↑ 9.6bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 3.9% = 4.8% × 0.33 × 2.51
2026Q1 2.6% = 3.2% × 0.34 × 2.45

ROE fell from 3.9% to 2.6% — leverage weakened the most, though asset turnover still provided support.

Net margin: 3.2% -1.6pp Asset turnover: 0.34x +0.01x Leverage: 2.45x -0.06x

Is the profit sustainable?

Margins narrowed but earnings quality remains clean — pressure is mainly operational.

very positive positive stable watch under pressure

What is driving the margin?

Net margin fell to 3.22%, losing 1.6pp. The main pressure is Gross margin fell 2.3pp, outweighing the improvement in SG&A / Revenue fell 1.5pp (in addition, Other profit / Revenue rose 0.6pp added support while Net financial result / Revenue fell 1.4pp remained a drag).

Margin is under pressure from multiple sides — temporary and structural components need to be separated to properly assess the risk.

Profitability trend

Net Margin 3.22% −1.6pp
Gross Margin 17.75% −2.3pp
SG&A / Revenue 9.21% −1.5pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.

Is capital being deployed efficiently?

Track how much operating profit the business generates on invested capital.

Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC
NOPAT Margin
Capital Turnover 0.40x +0.02x
Average Invested Capital 2,691.9bn −63.1bn

Balance Sheet

ROIC above should be read with industry context — the balance sheet below adds perspective. Leverage is elevated, requiring monitoring — liabilities at 1.42x equity, net debt at 1.10x equity.

Over the last 12 months, working capital absorbed 76.0bn of cash, mainly because of higher receivables and lower payables. Part of that drag was offset by lower inventories.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables increased → lower CFO: −80.6bn
Inventories decreased → higher CFO: +56.8bn
Payables decreased → lower CFO: −52.2bn

Working Capital Efficiency

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 31.1 days versus the same period last year. The main moves came from DIO fell 23.0 days, DSO fell 2.9 days, and DPO rose 5.3 days.

All 3 drivers (collection, inventory, payables) are improving — working capital turnover is strengthening across the board.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 64.3 days −2.9 days
Inventory 79.2 days −23.0 days
Payables 74.7 days +5.3 days
Cash Conversion Cycle 68.8 days −31.1 days

Is financial risk significant?

Leverage is safe but FCF is negative at 88.8bn due to capex of 90.3bn — an investment choice, not an urgent risk.

Leverage & Liquidity

Leverage warrants monitoring, with net debt / equity at 1.10x and interest coverage only at 0.74x.

At present, short-term debt accounts for 44.5% of total debt, cash equals 0.9% of debt, and total debt stands at 1,441.7bn.

Watchpoints

Net leverage is elevated

Net debt / equity stands at 1.10x, increasing balance-sheet pressure.

Interest coverage is thin

Interest coverage is 0.74x, leaving limited room to absorb financing costs.

Leverage and liquidity trend

Net Debt / Equity 1.10x +0.04x
Interest Coverage 0.74x −0.79x
Cash / Debt 0.9% −9.8pp
Short-term Debt / Total Debt 44.5% +4.8pp
CFO / NI 0.05x −7.01x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 29.1bn in 2025, against investing cash flow of -67.0bn.

Post-investment cash flow was negative +37.9bn. Financing cash flow was negative +114.4bn.

CFO / net income was 0.05x.

After spending +90.3bn on fixed-asset investment, the business generated trailing free cash flow of −88.8bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 1.5bn −353.8bn
Cash Capex 90.3bn −30.5bn
FCF TTM −88.8bn −323.3bn

Investment Takeaway

The business is under real pressure, but the current picture has not turned broadly adverse. A notable area has clearly weakened, making the near-term outlook hard to call bright; even so, other parts of the business are still holding up, with margins remain under pressure remaining the main constraint, with net margin down 1.6 pp. The next watchpoint is capital efficiency.

Watchpoint: Capital efficiency needs cycle context.

Key risk: profitability remains under pressure, with trailing-12M net margin at 3.22% after a 1.6pp decline versus the same period last year.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
1,077.7 1,065.1 1,340.0 1,057.0 940.6
Cost of Goods Sold
892.1 855.3 1,109.2 821.6 0.0
Gross Profit
185.6 209.8 230.8 235.4 174.9
Financial Expenses
43.9 43.3 46.2 37.5 -35.1
Selling Expenses
4.5 4.9 6.0 6.1 -7.5
General and Administrative Expenses
105.0 134.4 134.0 117.0 -105.3
Operating Profit
34.6 30.2 51.1 79.6 38.3
Profit Before Tax
39.9 28.1 49.7 76.9 37.7
Net Income
31.5 21.7 39.4 60.2 29.3
Profit Attributable to Parent
31.5 21.7 39.4 60.2 29.4
Earnings per Share
7,007.00 191.00 347.00 530.00 371.00

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.